Ascendis Pharma A (ASND) Selling, General & Administrative (2014 - 2026)
Ascendis Pharma A (ASND) reported Selling, General & Administrative of -$201.48 million for the quarter ended Jun 30, 2026, compared with -$121.75 million a year earlier.
Powered by 
Analysis
Ascendis Pharma A (ASND) Selling, General & Administrative (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Ascendis Pharma A's Selling, General & Administrative came in at -$662.23 million; for the year ended Dec 31, 2025, it came in at $517.3 million, up 64.2% from the prior year.
- Selling, General & Administrative has a five-year compound annual growth rate of 41.4% (years ended Dec 2020 to Dec 2025).
- By year, Selling, General & Administrative came in at $315.11 million in the year ended Dec 31, 2024, -$286.02 million in the year ended Dec 31, 2023, $233.16 million in the year ended Dec 31, 2022 (+27.2%) and $183.24 million in the year ended Dec 31, 2021 (+100.5%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Selling, General & Administrative in data going back to the quarter ended Mar 31, 2014.
- The high point for year-over-year Selling, General & Administrative in five years was the quarter ended Jun 30, 2022 (growth of 41.8%); the low point was the quarter ended Dec 31, 2021 (a decline of 65.1%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at -$170.03 million (quarter ended Mar 31, 2026), -$158.14 million (quarter ended Dec 31, 2025) and -$132.58 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Ascendis Pharma A | 14.09 Bn | 10.33 Bn | 362.22 Mn | -201.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -201.48 Mn |
| Mar 31, 2026 | -170.03 Mn |
| Dec 31, 2025 | -158.14 Mn |
| Sep 30, 2025 | -132.58 Mn |
| Jun 30, 2025 | -121.75 Mn |
| Mar 31, 2025 | -106.29 Mn |
| Dec 31, 2024 | -85.72 Mn |
| Sep 30, 2024 | -76.69 Mn |
| Jun 30, 2024 | 80.03 Mn |
| Mar 31, 2024 | 72.55 Mn |
| Dec 31, 2023 | 68.83 Mn |
| Sep 30, 2023 | 69.25 Mn |
| Jun 30, 2023 | 76.53 Mn |
| Mar 31, 2023 | 71.42 Mn |
| Dec 31, 2022 | 57.70 Mn |
| Sep 30, 2022 | 61.17 Mn |
| Jun 30, 2022 | 60.38 Mn |
| Mar 31, 2022 | 53.22 Mn |
| Dec 31, 2021 | 55.26 Mn |
| Sep 30, 2021 | 46.33 Mn |
API Access
Ascendis Pharma A Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();